From: CRISPR/Cas9 Knockout Strategies to Ablate CCAT1 lncRNA Gene in Cancer Cells
ID | Term | Gene Count | p Valuea |
---|---|---|---|
GO:0004867 | serine-type endopeptidase inhibitor activity | 9 | 2.50E-04 |
GO:0016491 | oxidoreductase activity | 12 | 6.60E-04 |
GO:0005515 | protein binding | 171 | 9.60E-03 |
GO:0008236 | serine-type peptidase activity | 5 | 2.30E-02 |
GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding | 4 | 2.30E-02 |
GO:0004252 | serine-type endopeptidase activity | 10 | 3.10E-02 |
GO:0015485 | cholesterol binding | 4 | 3.30E-02 |
GO:0004029 | aldehyde dehydrogenase (NAD) activity | 3 | 3.30E-02 |
GO:0032810 | sterol response element binding | 2 | 3.40E-02 |
GO:0003727 | single-stranded RNA binding | 4 | 3.70E-02 |
GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3 | 4.10E-02 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 4 | 4.40E-02 |
GO:0005506 | iron ion binding | 7 | 4.70E-02 |
GO:0003779 | actin binding | 10 | 4.90E-02 |